Volatility's at record levels, and uncertainty abounds. What does it mean for you and your money? The Fool's here to help. Check out our ongoing coverage of the latest market events.  Read The Latest >>

Legg Mason’s Death Has Been Exaggerated

Inside Value recommendation Legg Mason (NYSE: LM) hasn’t caught a single break over the last year, between fund manager underperformance and soured money-market investments. With the stock down almost 50% year-to-date, fiscal year 2009 first-quarter results are an opportunity to look for signs of re-animation.

The structured investment vehicles (SIVs) in Legg’s money-market funds are a gift that keeps on giving – or taking away, in this case. The company recorded a $155 million net charge or $1.09 per diluted share for the quarter. The press release contains all sorts of adjusted metrics that remove the effects of this and other “one-time” charges. The trouble is, even the adjusted numbers are worse than those for the previous quarter.

The numbers worsened, but at a decreasing pace
If you look hard enough, you can see the glass a third full (half is asking a bit much). Although the profit margin, assets under management and net asset outflows all deteriorated, they did so at a decreasing rate with respect to the previous quarter. That suggests the firm’s performance may be bottoming out.

The firm is also diversifying its product offerings, including a big push in Global Equities, to include a new group with investment teams in the U.S., the U.K., and Singapore.

Say it ain’t so, Bill Miller
It’s difficult to talk about Legg Mason without referring to their flagship Value Trust fund and its manager, Bill Miller. The fund’s performance has been horrific over the past three years. In 2008, large positions in stocks such as Citigroup (NYSE: C), JPMorgan Chase (NYSE: JPM), UnitedHealth Group (NYSE: UNH) and General Electric (NYSE: GE) have contributed to a near 40% loss in the fund’s value. Legg’s equity assets under management are a casualty of that number, with approximately $11 billion in net outflows in the quarter.

The fact is, Legg Mason’s results are highly dependent on a single investment orientation (“value,” that is) and it doesn’t have a strong, centralized risk management function like BlackRock (NYSE: BLK). When value is out of favor, Legg’s name is mud.

Where I stand on this Legg
Where does that leave investors? Firstly, Legg Mason isn’t going anywhere – its balance sheet is very solid. Secondly, although I’ve been resistant to this conclusion, its franchise value has been impaired over the last eighteen months – that’s inescapable. The $5.4 billion question is, to what degree?

And finally, value doesn’t exist in a vacuum; investors need to consider the price they‘re being asked to pay for the stock. It looks to me like the decline in franchise value is more than compensated for by the freefall in the share price; it’s difficult for me to imagine that Legg shares don’t offer substantial value at these levels. All the same, it’s a situation I’m less comfortable with than I was previously and interested investors should arm themselves with tremendous patience.

Related Foolishness:

What do the unfolding financial crisis and ongoing market volatility mean for your money? The Fool's here with answers. Get the best of our daily commentary and analysis in your inbox simply by entering your email address in the box below.

Is Legg Mason an extreme buying opportunity? Find out why the team at Inside Value likes the company and the stock by taking a 30-day free trial -- you’ll get to see all the rest of their picks, too!

Alex Dumortier, CFA has no beneficial interest in any of the stock mentioned in this article. JPMorgan Chase is a Motley Fool Income Investor pick. UnitedHealth Group and Legg Mason are Motley Fool Inside Value selections. UnitedHealth Group is a Motley Fool Stock Advisor pick. The Fool owns shares of Legg Mason. The Fool has a disclosure policy.

Comment (0)
Recommended (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 693144, ~/articles/articlehandler.aspx, 10/16/2008 3:21:06 AM,

Sign up for FREE Motley Fool site access to keep reading:

“Legg Mason’s Death Has Been Exaggerated”

Signing up allows you to comment on articles and on the discussion boards.

It's completely FREE and will take only 10 seconds.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

.

Related Tickers

Legg Mason, Inc.

LM Down! $20.41 -3.63 (-15.10%) 4:02 PM
CAPS Rating:
874 Outperforms
72 Underperforms
Rate This Stock

Major Indices

S&P 500907.84 -9.04%
DJIA8,577.91 -7.87%
NASD1,628.33 -8.47%
Updated: 4:04:23 PM
Sponsored by:

The Motley Poll

What do you think will be the best performing sector over the next six months?

Sponsored by: